Quest Diagnostics acquires Celera - MarketLine Financial Deals

Quest Diagnostics acquires Celera

Quest Diagnostics acquires Celera - MarketLine Financial Deals
Quest Diagnostics acquires Celera
Published May 17, 2011
5 pages — Published May 17, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Quest Diagnostics Incorporated, through its wholly-owned subsidiary Spark Acquisition Corporation, has acquired all outstanding shares of Celera Corporation, a provider of personalized disease management solutions.

  
Source:
Document ID
MA55071_110322
Country
Ticker
DGX=US
Ticker
CRA=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Quest Diagnostics acquires Celera" May 17, 2011. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Quest-Diagnostics-acquires-Celera-2052-57881>
  
APA:
MarketLine Financial Deals. (2011). Quest Diagnostics acquires Celera May 17, 2011. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Quest-Diagnostics-acquires-Celera-2052-57881>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.